This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo
Back to library search

Public Auctions for Purchasing Medicines in Russia

May 2011
PharmaceuticalProcurement

Abstract

The Government of the Russian Federation spent about EUR 1 billion according to the recently published results of main public auctions for purchase of medicines for state-funded programs. Government forecasts predict this amount to increase in the long term. Public contracts shall serve as a guarantee of the delivery and due payment. So it is not surprising that pharmaceutical companies aspire to participate in public tenders. The Government objectives are to make public tenders fair and transparent in order to prevent elimination of the competition and fraud. In this article we will provide an overview and analyses of the Russian legislation regulating public tenders for conclusion of state contracts.

Author

Mariya Tsintsadze
Senior Legal Counsel, Protek Group, Russia

Biography I graduated from Moscow State Law Academy in 2005. Before joining Protek Group, I was a Legal councel at Evrazgroup http://www.evraz.com/. I specialise in commercial, administrative and tax law.

Company

Protek Group

Protek Group is one of one of the largest pharmaceutical company in Russia. The Group has diversified business interests and is active in all major segments of the pharmaceutical industry such as manufacture of medicinal products, wholesaling and retailing of pharmaceuticals, beauty and health products. The Group employs more than 12 thousand people. The Group is vertically integrated, which enables it to set up a complete product supply chain from Production to Wholesale to Retail sales. The Group’s key assets: CV Protek, a national distributor of pharmaceuticals, beauty and health products; Sotex, a manufacturer of medical products; and Rigla pharmacy chain. In 2002, as part of the Group’s restructuring, OAO Protek was set up as the Group’s parent company to consolidate the equity interests (shares) in its subsidiaries and associates. http://www.protek-group.ru/en/

Related Papers

Tears and Cheers - Preliminary Legal Analysis on Patient Groups in China
Patient groups, also known as patient organizations, are non-profit organizations which focus on the interests of majority patients with a particular disease or condition. The roles and activities of patient...Read more
Portrait image of Xiangjun Kong
Xiangjun Kong
Head of Strategic Partnership (Previously Head of Legal), Sanofi China, China